12 Panel Now, Serenity
Shop
Industries
Wholesale
Learn
About
Propoxyphene dip card – PPX 300 ng/mL single-panel urine drug test

Single Panel Drug Test Dip Card

Dip Card PPX/300ng Detecting Propoxyphene. Serenity Instant Urine Drug Screening Card

In stock, ships same business day

Price each at 25

$0.79

Total

$19.75

Minimum order 25. The buttons move between price steps; type any quantity above the minimum.

Add 25 more and pay $0.77 each.

Volume pricing

Public pricing. Accounts with a price list see their own prices after sign-in.

FREE SHIPPING 100 Dip cards, SAME DAY SHIPPING
FLAT RATE of $4.99 – all Orders Under 100 Dip cards

FDA Approved/ CLIA Waived Cutoff level
Propoxyphene (PPX)
300ng/ml
Choose Quantity Price per cup

About this test

Propoxyphene Dip Card – PPX 300 ng/mL Urine Drug Test

This Serenity single-panel propoxyphene dip card screens urine for propoxyphene (Darvon®, Darvocet®) at a 300 ng/mL cutoff – a low-cost way to add PPX to your testing program without buying a full multi-panel test.

Features

  • Detects propoxyphene (PPX) at a 300 ng/mL cutoff
  • Completes legacy panels that still require PPX
  • Results in about 5 minutes
  • Dip-and-read design – no droppers or pipettes needed
  • FDA cleared & CLIA waived for point-of-care screening
  • Individually sealed single-panel card with protective cap
  • As low as $0.33 per test with volume pricing, same-day shipping

Propoxyphene dip card – PPX 300 ng/mL single-panel urine drug test

At a Glance

Test strip PPX - testing drug strip in drug testing kit
Drug detected Propoxyphene (PPX)
Cutoff level 300 ng/mL
Typical detection window Typically 1–2 days after last use (longer after repeated use)*
Specimen Urine
Read time 5 minutes (do not read after 10 minutes)
Format Single-panel dip card with cap, individually sealed foil pouch
Regulatory status FDA cleared / CLIA waived

*Detection windows are approximate and vary with dose, frequency of use, metabolism, hydration and kidney function.

What Is Propoxyphene?

Propoxyphene is an opioid pain reliever that was sold under brand names such as Darvon® and Darvocet®. The FDA asked manufacturers to withdraw it from the U.S. market on November 19, 2010, because it could cause dangerous heart rhythm problems at normal doses. It was also withdrawn in Europe, Canada and several other countries.

Why Test for Propoxyphene?

Although propoxyphene is no longer prescribed in the U.S., some drug testing programs, contracts and legacy panels still include PPX, and old supplies or products obtained outside the U.S. can still circulate. A single-panel PPX card lets you meet those requirements affordably.

How to use a single-panel drug test dip card: open, dip, read

How to Use the Propoxyphene Dip Card

  1. Remove the dip card from the sealed foil pouch and take off the cap.
  2. Dip the exposed test strip into the urine sample for 10–15 seconds.
  3. Allow the urine to migrate up the test strip.
  4. Replace the cap and lay the dip card flat on a clean, dry, non-absorbent surface.
  5. Read the results at 5 minutes. Do not read after 10 minutes.

How to Read Propoxyphene Dip Card Results

Drug Test Strips Positive Result

Positive

Only one colored line appears, in the control region (C). No line appears in the test region (T). This means propoxyphene was detected at or above 300 ng/mL.

Drug Test Strips Negative Result

Negative

Two colored lines appear: one in the control region (C) and one in the test region (T). Any line in the T region, even a very faint one, counts as negative.

Drug Test Strips Invalid Result

Invalid

No line appears in the control region (C). Discard the result and repeat the test with a new dip card. If the problem persists, stop using the lot and contact 12 Panel Now.

single dip cards

Propoxyphene Dip Card – Frequently Asked Questions


What is propoxyphene?

Propoxyphene is an opioid pain medication formerly sold as Darvon® and Darvocet® (propoxyphene with acetaminophen). In the body it is converted to norpropoxyphene, a metabolite that stays in the body longer than the parent drug.


Is propoxyphene still prescribed?

No. The FDA requested its withdrawal from the U.S. market on November 19, 2010, after data showed it could cause serious heart rhythm abnormalities even at typical doses. Europe, Canada, New Zealand and other countries also removed it from their markets.


Why test for propoxyphene if it was discontinued?

Some testing programs, contracts and legacy drug panels still require PPX, and older supplies or products obtained outside the U.S. may still be in circulation. This single-panel card lets you complete those requirements without paying for a larger multi-panel test.


How long does propoxyphene stay in urine?

Propoxyphene has a half-life of about 6–12 hours, while its metabolite norpropoxyphene has a half-life of about 30–36 hours. Use is typically detectable for about 1–2 days, and can be detectable longer after repeated use.


Will other opioids cause a positive PPX result?

The PPX test is designed to detect propoxyphene. Other opioids such as morphine, oxycodone, fentanyl and methadone require their own tests. Refer to the package insert for any compounds that may cross-react.


How do I read a very faint line?

Any visible line in the test region (T), even a very faint one, means the result is negative. The result is positive only when a line appears in the control region (C) and no line appears in the test region (T).


Is a positive result final?

No. This is a rapid screening test that gives a preliminary result. Confirm non-negative results with a laboratory test such as GC/MS or LC-MS/MS before making treatment, employment or legal decisions.

Also Available

The 12 Panel Now Advantage

  • Wholesale pricing – as low as $0.33 per dip card with volume discounts.
  • Same-day shipping on in-stock orders from our U.S. warehouse.
  • Free shipping on 100+ dip cards; flat rate of $4.99 on smaller orders.
  • Resellers & drop shipping – bulk, private label and drop-ship programs available.

Clinical Use Product

This dip card is FDA cleared and CLIA waived, making it suitable for point-of-care screening in physician offices, clinics, treatment programs and workplace testing programs when used according to the package insert. Facilities performing clinical testing may need a CLIA Certificate of Waiver.

Screening results are preliminary. Confirm non-negative results with a laboratory method such as GC/MS or LC-MS/MS. This device is not designated for forensic use.